{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:57Z","timestamp":1787698317713,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Province Traditional Chinese medicine science and technology project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10735-025-10405-7","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:16:59Z","timestamp":1751066219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exendin-4 alleviates diabetic retinopathy by activating autophagy via regulation of the adenosine monophosphate-activated protein kinase\/sirtuin 1 pathway"],"prefix":"10.1007","volume":"56","author":[{"given":"Jufen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"10405_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.695267","volume":"12","author":"A Adornetto","year":"2021","unstructured":"Adornetto A, Gesualdo C, Lagan\u00e0 ML, Trotta MC, Rossi S, Russo R (2021) Autophagy: a novel pharmacological target in diabetic retinopathy. Front Pharmacol 12:695267","journal-title":"Front Pharmacol"},{"issue":"1","key":"10405_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/dc20-1815","volume":"44","author":"MA Bethel","year":"2021","unstructured":"Bethel MA, Diaz R, Castellana N, Bhattacharya I, Gerstein HC, Lakshmanan MC (2021) HbA(1c) change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression. Diabetes Care 44(1):290\u2013296","journal-title":"Diabetes Care"},{"issue":"4","key":"10405_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11892-012-0283-6","volume":"12","author":"J Ding","year":"2012","unstructured":"Ding J, Wong TY (2012) Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 12(4):346\u2013354","journal-title":"Curr Diab Rep"},{"issue":"2","key":"10405_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7861\/clinmed.2021-0792","volume":"22","author":"TH Fung","year":"2022","unstructured":"Fung TH, Patel B, Wilmot EG, Amoaku WM (2022) Diabetic retinopathy for the non-ophthalmologist. Clin Med 22(2):112\u2013116","journal-title":"Clin Med"},{"issue":"1","key":"10405_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221(1):3\u201312","journal-title":"J Pathol"},{"key":"10405_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1476-511X-13-156","volume":"13","author":"Y Gong","year":"2014","unstructured":"Gong Y, Jin X, Wang QS, Wei SH, Hou BK, Li HY, Zhang MN, Li ZH (2014) The involvement of high mobility group 1 cytokine and phospholipases A2 in diabetic retinopathy. Lipids Health Dis 13:156","journal-title":"Lipids Health Dis"},{"key":"10405_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.644121","volume":"8","author":"Q Gong","year":"2021","unstructured":"Gong Q, Wang H, Yu P, Qian T, Xu X (2021) Protective or harmful: the dual roles of autophagy in diabetic retinopathy. Front Med (Lausanne) 8:644121","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10405_CR8","doi-asserted-by":"publisher","first-page":"11694","DOI":"10.1080\/21655979.2022.2070997","volume":"13","author":"Y Gong","year":"2022","unstructured":"Gong Y, Li X, Xie L (2022) Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p\/transforming growth factor beta 2 axis. Bioengineered 13(5):11694\u201311705","journal-title":"Bioengineered"},{"issue":"3","key":"10405_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ando.2008.03.004","volume":"69","author":"B Guerci","year":"2008","unstructured":"Guerci B, Martin CS (2008) Exenatide: its position in the treatment of type 2 diabetes. Ann Endocrinol 69(3):201\u2013209","journal-title":"Ann Endocrinol"},{"issue":"1","key":"10405_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dbi17-0013","volume":"67","author":"C Hu","year":"2018","unstructured":"Hu C, Jia W (2018) Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 67(1):3\u201311","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10405_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1900\/RDS.2015.12.159","volume":"12","author":"AJ Jenkins","year":"2015","unstructured":"Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O\u2019Neal DN, Januszewski AS (2015) Biomarkers in diabetic retinopathy. Rev Diabet Stud 12(1\u20132):159\u2013195","journal-title":"Rev Diabet Stud"},{"issue":"8","key":"10405_CR12","first-page":"1182","volume":"32","author":"S Ke","year":"2012","unstructured":"Ke S, Xue Y, Li C, Zhu B, Fu C (2012) Exendin-4 ameliorates high glucose- and TNF-\u03b1-induced vascular endothelial cell damage by inhibiting p38 MAPK and NF-\u03baB p65 translocation. Nan Fang Yi Ke Da Xue Xue Bao 32(8):1182\u20131185","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10405_CR13","first-page":"75","volume":"107","author":"AN Kollias","year":"2010","unstructured":"Kollias AN, Ulbig MW (2010) Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int 107(5):75\u201383","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"10405_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998253672231011161400","volume":"20","author":"V Kour","year":"2024","unstructured":"Kour V, Swain J, Singh J, Singh H, Kour H (2024) A review on diabetic retinopathy. Curr Diabetes Rev 20(6):e201023222418","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"10405_CR15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","volume":"39","author":"JL Leasher","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY et al (2016) Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis From 1990 to 2010. Diabetes Care 39(9):1643\u20131649","journal-title":"Diabetes Care"},{"key":"10405_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-981-15-0602-4_4","volume":"1206","author":"Y Li","year":"2019","unstructured":"Li Y, Chen Y (2019) AMPK and autophagy. Adv Exp Med Biol 1206:85\u2013108","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10405_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/13813455.2021.1887266","volume":"129","author":"L Li","year":"2023","unstructured":"Li L, Chen J, Zhou Y, Zhang J, Chen L (2023) Artesunate alleviates diabetic retinopathy by activating autophagy via the regulation of AMPK\/SIRT1 pathway. Arch Physiol Biochem 129(4):943\u2013950","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"10405_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000487486","volume":"61","author":"W Lin","year":"2019","unstructured":"Lin W, Xu G (2019) Autophagy: a role in the apoptosis, survival, inflammation, and development of the retina. Ophthalmic Res 61(2):65\u201372","journal-title":"Ophthalmic Res"},{"issue":"8","key":"10405_CR19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/jdi.13480","volume":"12","author":"KY Lin","year":"2021","unstructured":"Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ (2021) Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig 12(8):1322\u20131325","journal-title":"J Diabetes Investig"},{"key":"10405_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2023.2274279","volume":"131","author":"J Liu","year":"2023","unstructured":"Liu J, Wang H, Huang C (2023) Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro. Arch Physiol Biochem 131:1\u201310","journal-title":"Arch Physiol Biochem"},{"key":"10405_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173893","volume":"895","author":"Y Luo","year":"2021","unstructured":"Luo Y, Dong X, Lu S, Gao Y, Sun G, Sun X (2021) Gypenoside XVII alleviates early diabetic retinopathy by regulating M\u00fcller cell apoptosis and autophagy in db\/db mice. Eur J Pharmacol 895:173893","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10405_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajpath.2016.08.022","volume":"187","author":"S Roy","year":"2017","unstructured":"Roy S, Kern TS, Song B, Stuebe C (2017) Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy. Am J Pathol 187(1):9\u201319","journal-title":"Am J Pathol"},{"key":"10405_CR23","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"TE Tan","year":"2022","unstructured":"Tan TE, Wong TY (2022) Diabetic retinopathy: looking forward to 2030. Front Endocrinol (Lausanne) 13:1077669","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10405_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E (2008) LC3 and autophagy. Methods Mol Biol 445:77\u201388","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10405_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y et al (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580\u20131591","journal-title":"Ophthalmology"},{"issue":"4","key":"10405_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2213-8587(19)30411-5","volume":"8","author":"S Vujosevic","year":"2020","unstructured":"Vujosevic S, Aldington SJ, Silva P, Hern\u00e1ndez C, Scanlon P, Peto T, Sim\u00f3 R (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8(4):337\u2013347","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10405_CR27","doi-asserted-by":"publisher","first-page":"1015500","DOI":"10.3389\/fphys.2022.1015500","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Li H, Yuan M, Fan H, Cai Z (2022) Role of AMPK in autophagy. Front Physiol 13:1015500","journal-title":"Front Physiol"},{"issue":"9","key":"10405_CR28","doi-asserted-by":"publisher","first-page":"107680","DOI":"10.1016\/j.isci.2023.107680","volume":"26","author":"YC Wang","year":"2023","unstructured":"Wang YC, Wang L, Shao YQ, Weng SJ, Yang XL, Zhong YM (2023) Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes. Iscience 26(9):107680","journal-title":"Iscience"},{"key":"10405_CR29","doi-asserted-by":"publisher","first-page":"1861940","DOI":"10.1155\/2022\/1861940","volume":"2022","author":"L Wei","year":"2022","unstructured":"Wei L, Mo W, Lan S, Yang H, Huang Z, Liang X, Li L, Xian J, Xie X, Qin Y et al (2022) GLP-1 RA improves diabetic retinopathy by protecting the blood-retinal barrier through GLP-1R-ROCK-p-MLC signaling pathway. J Diabetes Res 2022:1861940","journal-title":"J Diabetes Res"},{"issue":"2","key":"10405_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1167\/iovs.11-8695","volume":"53","author":"B Xie","year":"2012","unstructured":"Xie B, Jiao Q, Cheng Y, Zhong Y, Shen X (2012) Effect of pigment epithelium-derived factor on glutamate uptake in retinal muller cells under high-glucose conditions. Invest Ophthalmol vis Sci 53(2):1023\u20131032","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10405_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-981-15-0602-4_5","volume":"1206","author":"HD Xu","year":"2019","unstructured":"Xu HD, Qin ZH (2019) Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol 1206:109\u2013126","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10405_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/1753-0407.13373","volume":"15","author":"X Yang","year":"2023","unstructured":"Yang X, Huang Z, Xu M, Chen Y, Cao M, Yi G, Fu M (2023) Autophagy in the retinal neurovascular unit: new perspectives into diabetic retinopathy. J Diabetes 15(5):382\u2013396","journal-title":"J Diabetes"},{"issue":"1121","key":"10405_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/postgradmedj-2018-136102","volume":"95","author":"Y Yao","year":"2019","unstructured":"Yao Y, Du J, Li R, Zhao L, Luo N, Zhai JY, Long L (2019) Association between ICAM-1 level and diabetic retinopathy: a review and meta-analysis. Postgrad Med J 95(1121):162\u2013168","journal-title":"Postgrad Med J"},{"issue":"5","key":"10405_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/bcpt.13169","volume":"124","author":"MKK Yap","year":"2019","unstructured":"Yap MKK, Misuan N (2019) Exendin-4 from Heloderma suspectum venom: from discovery to its latest application as type II diabetes combatant. Basic Clin Pharmacol Toxicol 124(5):513\u2013527","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"15","key":"10405_CR35","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1111\/bph.15059","volume":"177","author":"R Zhai","year":"2020","unstructured":"Zhai R, Xu H, Hu F, Wu J, Kong X, Sun X (2020) Exendin-4, a GLP-1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia-reperfusion injury. Br J Pharmacol 177(15):3389\u20133402","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10405_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00417-008-1004-3","volume":"247","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Wang Q, Zhang J, Lei X, Xu GT, Ye W (2009) Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 247(5):699\u2013706","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10405_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114772","volume":"284","author":"XX Zhang","year":"2022","unstructured":"Zhang XX, Ji YL, Zhu LP, Wang ZH, Fang CQ, Jiang CH, Pan K, Zhang J, Yin ZQ (2022a) Arjunolic acid from Cyclocaryapaliurus ameliorates diabetic retinopathy through AMPK\/mTOR\/HO-1 regulated autophagy pathway. J Ethnopharmacol 284:114772","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10405_CR38","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.4081\/ejh.2022.3522","volume":"66","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhou M, Cai X, Zhou Y, Jiang X, Luo Y, Hu Y, Qiu R, Wu Y, Zhang Y et al (2022b) VEGF promotes diabetic retinopathy by upregulating the PKC\/ET\/NF-\u03baB\/ICAM-1 signaling pathway. Eur J Histochem 66(4):3522","journal-title":"Eur J Histochem"},{"issue":"3","key":"10405_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/cells8030213","volume":"8","author":"P Zhou","year":"2019","unstructured":"Zhou P, Xie W, Meng X, Zhai Y, Dong X, Zhang X, Sun G, Sun X (2019) Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells 8(3):213","journal-title":"Cells"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:32:31Z","timestamp":1757201551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10405"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10405-7","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Minor correction in affiliation","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental and animal care procedures were approved by Shangyu People\u2019s Hospital of Shaoxing City (Approval Number. 2022YB032) and adhered to the guidelines of the National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"210"}}